Clinical Trial Update: A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating metronomic cyclophosphamide (CP) and JX-594 in patients with advanced breast cancer and advanced soft-tissue sarcoma. S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• JX-594
• metronomic CP (cyclophosphamide)

Snippet

Sponsor: Institut Bergonié | Conditions: Solid Tumors, Soft-tissue Sarcoma | Phase 1, Phase 2 | Status: UNKNOWN